Memorial Sloan Kettering Cancer Center’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.04M | Hold |
191,176
| – | – | 4.24% | 3 |
|
|
2023
Q2 | $1.3M | Hold |
191,176
| – | – | 4.1% | 4 |
|
|
2023
Q1 | $958K | Hold |
191,176
| – | – | 2.94% | 5 |
|
|
2022
Q4 | $933K | Hold |
191,176
| – | – | 3.08% | 5 |
|
|
2022
Q3 | $2.76M | Hold |
191,176
| – | – | 9.37% | 3 |
|
|
2022
Q2 | $2.89M | Hold |
191,176
| – | – | 9.56% | 3 |
|
|
2022
Q1 | $2.27M | Hold |
191,176
| – | – | 2.63% | 6 |
|
|
2021
Q4 | $3.1M | Sell |
191,176
-25,740
| -12% | -$417K | 1.95% | 6 |
|
|
2021
Q3 | $6.19M | Hold |
216,916
| – | – | 3.86% | 6 |
|
|
2021
Q2 | $7.33M | Hold |
216,916
| – | – | 4.79% | 4 |
|
|
2021
Q1 | $6.56M | Hold |
216,916
| – | – | 4.04% | 4 |
|
|
2020
Q4 | $10.7M | Buy |
+216,916
| New | +$10.7M | 4.55% | 4 |
|